EUCTR2010-023233-30-NL进行中（未招募）不适用
‘Intravenous iron treatment in iron deficient patients with pulmonary arterialhypertension' - Treating iron deficiency in PAH
VU university medical center0 个研究点目标入组 30 人开始时间: 2010年10月6日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Stable idiopathic pulmonary arterial hypertension (stable disease for at least 3 months)
- •- iron deficiency (serum iron below 10 µmol/l, decreased transferrin saturation (<15% in females and <20% in males) and serum ferritin <100 µg/l) irrespective of the coexistence of anaemia
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Current iron therapy (oral or iv)
- •- Current other study medication for PAH
- •- History of anaemia or current treatment of anaemia
- •- Liver function impairment
- •- Chronic disease other than PAH ( rheumatism, asthma, chronic infection)
- •- Acute infection
研究者
相似试验
尚未招募
4 期
Intravenous iron for treatment of Sub-optimal iron stores in Non-Anaemic Patients presenting for major SurgeryIron deficiencyBlood - AnaemiaSurgery - Other surgeryACTRN12620000314921The University of Western Australia50
进行中（未招募）
1 期
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatioiron deficiency anemiaEUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
进行中（未招募）
1 期
Intravenous iron supplement for patients with severe aortic stenosis who have iron deficiencyIron deficiency, aortic stenosisMedDRA version: 20.0 Level: HLT Classification code 10022971 Term: Iron deficiencies System Organ Class: 100000004861EUCTR2019-002037-11-NOOslo University Hospital100
进行中（未招募）
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
尚未招募
3 期
Haem iron supplementation to combat iron deficiency and anaemia in African children - IDeA Study 3Nutritional, Metabolic, EndocrinePaediatricsPACTR202210523178727Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine208